Thursday, 15 October 2026 | 15:10 - 16:30
Thematic session 4 – From promise to impact: How innovations successfully scale and reach patients
- Nuclear medicine
- Radioligand therapy (RLT)
- Radiotheranostics
- Oncology
- Precision medicine
- Health innovation
- Clinical innovation
- Patient impact
- Innovation ecosystem
- Scaling innovation
- Public-private partnerships
- Academic-industry collaboration
- Market access
- Belgian excellence
This session will showcase Belgium’s excellence in nuclear medicine through concrete examples of innovation transforming clinical practice.
Key highlights include:
-
Three compelling success stories from leading Belgian actors
-
The development of breakthrough therapies and enabling technologies
-
The role of novel radioisotopes in advancing the field
-
How innovation moves from concept to clinical application
-
The tangible and measurable impact on patients
The session will also emphasize:
-
The strength and complementarity of the Belgian ecosystem
-
A broader view of national capabilities in nuclear medicine
It will conclude with:
-
A high-level roundtable gathering C-level leaders
-
A strategic discussion on how to sustain and strengthen
-
Belgium’s global leadership in a fast-evolving, competitive landscape
Why attend?
Understand how local excellence can drive global impact, and identify the key conditions needed to turn innovation into meaningful patient outcomes.
1 speaker
CEO
PanTera nv